News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EMD Millipore Press Briefings at INTERPHEX



4/3/2013 10:01:53 AM

April 03, 2013 -- Visit with the EMD Millipore team at INTERPHEX 2013 to learn how customer need is driving innovation in single-use technology. See firsthand how the unique connectivity and modularity of our Mobius® processing systems improve the bioproduction process by reducing risk, decreasing cost and speeding time to clinic.

Find out about our comprehensive chemicals offering (including cell culture media, buffers and CIP), which, when paired with our processing systems, provides customers with complete upstream and downstream solutions.

Complete, Single-use Process Train

View the industry's leading complete, single-use process train and see how the latest advances on the Mobius® FlexReady and CellReady solutions can offer you:

• Ready-to-implement solutions with scalable, industry-leading cell culture, separation and purification technologies

• The highest level of flexibility for multi-product, multi-scale facilities with modular units for scaling up/down and across unit operations

• Innovative Smart Flexware® single-use flow paths (for our chromatography and TFF systems) reduce the risk of cross contamination and the risk of operator error by minimizing the number of connections required

Cellvento™ CHO media platform

Learn about EMD Millipore's new proprietary CHO media platform specifically designed for the long-term growth of Chinese Hamster Ovary (CHO) cells in suspension, and for the expression of antibodies or recombinant proteins. Cellvento™ media are chemically defined, of non-animal origin and produced as a high quality dry powder in our cGMP-compliant manufacturing facility, using the finest qualified materials available providing: excellent productivity profile, high media consistency, reliable homogeneity and a comprehensive documentation package.

Attend two EMD Millipore presentations at INTERPHEX:

Current Continuous Process Validation Program (CCVP) Following FDA Current Guidelines

Presented by Victor Hernandez

Sustainable Engineering, Project Engineer, EMD Millipore

Wednesday, April 24, 2013, 1:30pm-2:30pm, Room 1E08

Conversion of a Stainless Steel Facility to Hybrid or Single-use Facility

Presented by Roman Rodriguez

Mobius Group Global Manager, EMD Millipore

Wednesday, April 24, 2013, 4:00pm-4:45pm, Room 1E09

To schedule a meeting with EMD Millipore in advance, please contact:

Leslie Eisenberg

Feinstein Kean Healthcare

leslie.eisenberg@fkhealth.com

(617) 244-3872

At INTERPHEX, please contact:

Ian Davis

EMD Millipore

Ian.davis@emdmillipore.com

978-430-9392

Follow us on Twitter as we tweet live from #INTERPHEX at @EMDMilliporePS.

About EMD Millipore

EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany


Read at BioSpace.com

Related News

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES